In brief There is no single age limit that determines whether every patient can or cannot have deep brain stimulation. Age is an important consideration, but it is not assessed on its own. Overall health, cognitive function, balance, symptom pattern, response to levodopa and expected functional benefit are usually more important than the number on a patient’s passport. A fit patient in their seventies may be a more appropriate DBS candidate than a younger patient whose sympto

In brief Deep brain stimulation may significantly improve selected movement symptoms of Parkinson’s disease, particularly tremor, rigidity, slowness and medication-related motor fluctuations. However, DBS is not a cure for Parkinson’s disease and does not stop the condition from progressing. The degree of benefit varies between patients, making careful selection and realistic expectations essential. Which symptoms usually respond best? DBS generally works best for motor sympt

In brief Most patients return gradually to walking and ordinary daily activities after DBS surgery. Exercise remains important for mobility, balance, cardiovascular health and independence in Parkinson’s disease. The timing depends on wound healing, balance, fall risk and the type of activity. The early recovery period During the initial healing period, patients are generally advised to: Take regular short walks Rest when fatigued Keep incisions clean and dry Avoid lifting he

In brief Many modern DBS systems allow certain MRI examinations under specific conditions. This does not mean every scanner, body region or protocol is automatically safe. Airport security is also generally manageable, but patients should carry their device identification card and inform security personnel about the implant. Can I have an MRI? MRI safety depends on: The exact DBS manufacturer and model Which components are implanted Whether the system is complete and function

In brief Successful DBS treatment continues after surgery. The device must be activated, programmed and adjusted according to symptoms and side effects. International patients need a written follow-up plan before returning home. When does programming begin? Initial programming commonly begins after the brain and incision sites have had time to recover. The exact schedule differs between centres. Several sessions may be required to identify settings that improve symptoms witho

In brief There is no universal number of days after DBS surgery when every patient can safely fly. Clearance depends on neurological recovery, wound condition, postoperative imaging, the presence of complications and the duration of the flight. The operating team should approve the individual travel date. Why might flying be delayed? Return travel may be postponed if there is: Significant headache or confusion New weakness or speech difficulty Wound swelling, redness or disch

In brief There is no single appropriate stay for every DBS patient. The plan depends on whether surgery is completed in one or two stages, wound healing, neurological recovery, device activation and the timing of the first postoperative review. International patients should not arrange an inflexible return flight before the surgical plan is confirmed. Hospital stay Many patients remain in hospital for approximately one to three days after brain-lead placement, although indivi

In brief International DBS treatment should begin with medical review—not flight or hotel reservations. Before travelling, the clinical team should assess the Parkinson’s diagnosis, medication response, general health and available imaging. The final treatment plan is confirmed after the required in-person examinations. Step 1: Preliminary record review Patients may be asked to send: Neurology reports Medication list Brain MRI images Videos from “on” and “off” periods Medical

In brief An online consultation can provide a useful preliminary assessment for Parkinson’s patients considering deep brain stimulation abroad. Medical records, medication response, symptom videos and previous imaging can be reviewed remotely. However, final DBS candidacy generally requires an in-person neurological examination, levodopa assessment, neuropsychological evaluation and surgical review. What can be assessed online? The initial consultation may review: Confirmatio

In brief DBS battery life depends on the type of implantable pulse generator and the amount of energy required for stimulation. A non-rechargeable generator may require replacement after several years. Rechargeable systems can function considerably longer but require regular charging. Exact longevity cannot be guaranteed before programming begins. Where is the DBS battery located? The implantable pulse generator is usually positioned beneath the skin of the upper chest. Exten

In brief Most people continue taking some Parkinson’s medication after deep brain stimulation. DBS may allow medication doses to be reduced, particularly when motor fluctuations or dyskinesia are major problems, but it does not replace every function of medication. Changes should be made gradually by the movement-disorders team after stimulation has been programmed. Why are medications continued? DBS primarily helps selected movement symptoms such as: Tremor Rigidity Bradykin

In brief Evaluation for deep brain stimulation is not based on a single scan or examination. It usually includes confirmation of the Parkinson’s diagnosis, an assessment of medication response, brain imaging, cognitive and psychological testing and a general medical review. The purpose is to determine whether DBS is likely to address the patient’s main symptoms and whether surgery can be performed safely. Evaluation by a movement-disorders neurologist The first step is usuall

In brief The subthalamic nucleus (STN) and the internal globus pallidus (GPi) are the two most frequently selected targets for deep brain stimulation in Parkinson’s disease. Both can improve appropriate levodopa-responsive motor symptoms. The choice is not simply about which target is “better”; it depends on the patient’s symptoms, medication goals, cognitive and psychiatric profile, age and the experience of the multidisciplinary DBS team. What are the STN and GPi? The STN a

In brief A patient does not always have to remain awake during deep brain stimulation surgery. DBS lead placement can be performed while the patient is awake with local anaesthesia and light sedation, or while the patient is asleep under general anaesthesia. The most appropriate approach depends on the patient, the surgical target, the technology available and the DBS team’s preferred method. Why are some patients awake during DBS surgery? During awake DBS, the scalp is numbe

In brief: DBS surgery involves placing one or two thin electrodes into carefully selected brain targets and connecting them, through wires beneath the skin, to a programmable pulse generator usually implanted near the collarbone. The process includes detailed patient assessment, imaging-based planning, electrode placement, device implantation and postoperative programming. Step 1: Confirming that DBS is appropriate The process begins before the operating room. DBS is not sele

In brief: DBS is most effective for selected motor symptoms such as tremor, rigidity, bradykinesia, motor fluctuations and dyskinesias. Balance problems, levodopa-resistant freezing, speech and swallowing difficulties, cognitive impairment and many autonomic symptoms are less likely to improve consistently DBS does not treat every feature of Parkinson’s disease Deep brain stimulation can provide substantial benefit for appropriately selected patients, but it does not cure Par

In brief: Recovery after deep brain stimulation does not end when the operation is completed. The incisions must heal, the stimulation system must be activated and the settings must then be adjusted to the patient’s individual symptoms. The best result may require several programming sessions rather than one immediate adjustment. What happens immediately after DBS surgery? After electrode placement, the medical team monitors neurological findings, blood pressure, alertness an

In brief: Deep brain stimulation is an established treatment for carefully selected people with Parkinson’s disease, but it is not risk-free. Possible problems can be divided into surgical complications, device-related complications and stimulation-related side effects. Many stimulation side effects can be improved by adjusting the DBS settings. Understanding the three types of DBS risk When discussing DBS, it is helpful to separate potential problems into three categories: R

In brief: Deep brain stimulation usually provides its most predictable benefits for tremor, rigidity, slowness of movement, motor fluctuations and dyskinesias. Symptoms that improve with levodopa generally have a better chance of responding to DBS, although medication-resistant tremor can be an important exception. DBS does not affect every Parkinson’s symptom equally Deep brain stimulation, or DBS, is a surgical treatment used to control selected symptoms of Parkinson’s dise

In brief: The right time to consider a DBS evaluation is usually when Parkinson’s motor symptoms still respond to levodopa, but medication no longer provides consistent control throughout the day. Troublesome “off” periods, dyskinesia or disabling tremor are common reasons for referral. Patients do not necessarily need to wait until the disease becomes very advanced. Deep brain stimulation is often described as a treatment of last resort. This description can be misleading. D